However, its role in fulvestrant sensitivity and the therapeutic potential of targeted BRD4 degradation require further investigation.<h4>Methods</h4>We assessed BRD4 transcriptional activity in breast cancer and its functional role in tumor progression and endocrine sensitivity. This evidence concerns the gene BRD4 and breast carcinoma.